OQI
5 FDA 510(k) clearances · Product code
263 daysmedian time to decision
370 days90th percentile
5clearances measured
FDA profile
- Official device name
- Hip, Semi-Constrained, Cemented, Metal/Ceramic/Polymer + Additive, Porous Uncemented
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 888.3353
- Medical specialty
- Orthopedic
- Flags
- Implant
- FDA definition
- 1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. 5. Revision procedures where other treatment or devices have failed. Cemented and uncemented use.
- Adverse events (MAUDE)
- 2015: 9 · 2016: 17 · 2023: 23 · 2024: 35 · 2025: 45 · 2026: 14
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| EPORE® XO cup system (K252451) | Implantcast GmbH | 2026-04-24 |
| Libertas E-XLPE Modular Liner (K192989) | Maxx Orthopedics, Inc. | 2020-10-29 |
| E-XPE Acetabular Components and U-Motion II Acetabular Cup (K172833) | United Orthopedic Corporation | 2018-06-12 |
| Exactech® Novation® and AcuMatch® E-HXL Acetabular Liners (K173583) | Exactech, Inc. | 2018-03-12 |
| CORIN TRINITY ACETABULAR SYSTEM ECIMA LINERS (K111481) | Corin USA | 2012-02-06 |
Track OQI automatically
Every clearance here is in the API, with alerts when new ones post.